A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy

Shubhashish Sarkar(Methodist Hospital), Pomila Singh(The University of Texas Medical Branch at Galveston)

Laboratory Investigation

April 17, 2017

10.1038/labinvest.2017.40

Cited by 40

Related Papers

Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications

|Scientific Reports|2015|73